noncancer

Morgan Stanley also raised concerns about Roche's other noncancer research pipeline.

Blockbuster Odds Dim for Roche 2010

Also review your noncancer medical history with your doctor.

The 10 Best Questions Dede Bonner 2008

Cephalon, of Frazer, Pa., will appear before an FDA advisory committee Tuesday to make its case that there is a need to expand Fentora's use for noncancer patients.

FDA Cites Risks to Expanding Cephalon Drug 2008

The Food and Drug Administration will tell an outside panel of medical experts Tuesday that expanding Cephalon Inc. 's pain reliever Fentora to treat noncancer patients poses significant risks of overdose, misuse and abuse.

FDA Cites Risks to Expanding Cephalon Drug 2008

The company said there is a "definitive need" for expanding Fentora's use to noncancer patients because there is no other FDA-approved drug "for the management of breakthrough pain in patients being treated with around-the-clock opioids."

FDA Cites Risks to Expanding Cephalon Drug 2008

Also review your noncancer medical history with your doctor.

The 10 Best Questions Dede Bonner 2008

Even more devastating are dioxin's noncancer effects: reproductive abnormalities, liver damage, diabetes-like symptoms and immune-system suppression, which increases susceptibility to infection and metastatic cancer.

Don't Drink The Dioxin 2008

WASHINGTON -- A Food and Drug Administration panel didn't recommend approving expanded use of Cephalon Inc. 's powerful pain reliever Fentora for noncancer patients.

FDA Panel Rejects Wider Use of Painkiller 2008

Moreover, says the EPA's Dr. Lynn Goldman, who oversees the three-year study, "we [now] have stronger evidence that dioxin exposure can result in a number of noncancer health effects."

Don't Drink The Dioxin 2008

Panel members said at a meeting in Gaithersburg, Md., that they weren't convinced that Fentora does a better job treating noncancer patients with chronic pain than other drugs on the market, despite evidence that 80% of Fentora prescriptions are written for noncancer patients.

FDA Panel Rejects Wider Use of Painkiller 2008